how to tell if retatrutide is working vs Tirzepatide Retatrutide Dosing: Early Clinical Trial

CAIL 1% is for individuals seeking improved elasticity, volume, and tone

Your doctor may also prescribe medications for fatty liver disease like: These are often grouped together as glucagon-like peptide 1 (GLP-1) medications

primary-cta Is It FDA-Approved

It does not contain retinoids, hydroquinone, or other commonly restricted skincare ingredients

As Seen on CNN: You Cannot Ignore the GLP1 Effect A January 2026 CNN Smerconish segment featuring consumer behavior analyst Ali Furman laid it out clearly (video): People on these medications consume ~40% fewer calories and are spending about 5% less at quick-service restaurants. The GLP1 customer isnt eating out less theyre eating differently. Ali Furman, CNN Smerconish - Ali Furman, US Consumer Markets Industry Leader, PwC Furman shared that household penetration of GLP1s rose from 9% to 20% in 2025 , and with oral versions expected soon, usage will likely climb even further